Approval Year
Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 19:33:39 UTC 2023
by
admin
on
Sat Dec 16 19:33:39 UTC 2023
|
Source Materials Class | ORGANISM |
Source Materials Type | AUTOLOGOUS HUMAN |
Source Materials State | LIVE GENETICALLY MODIFIED |
Source Materials Parent | |
Part | BLOOD |
Fraction Material Type | CELL |
Fraction Name | CD3+ enriched T lymphocytes |
Record UNII |
22TCU7HE9E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
22TCU7HE9E
Created by
admin on Sat Dec 16 19:33:40 UTC 2023 , Edited by admin on Sat Dec 16 19:33:40 UTC 2023
|
PRIMARY | |||
|
12254
Created by
admin on Sat Dec 16 19:33:40 UTC 2023 , Edited by admin on Sat Dec 16 19:33:40 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->CYTOTOXIC T-CELL |
|
||
|
EXPRESSED PROTEIN->VECTOR |
|
||
|
EXPRESSED PROTEIN->VECTOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
cell-based gene therapy (antineoplastic)
|
Agent Modifications
Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
---|---|---|---|---|---|
CULTURE | EXPANSION | BIOLOGICAL | HUMAN INTERLEUKIN-2 | FNO32LO217 | |
LENTIVIRAL TRANSFECTION | TRANSFECTION | BIOLOGICAL | Pomlucabtagene autoleucel retroviral vector | 6TE68QHJ9Q | |
CULTURE | ACTIVATOR | BIOLOGICAL | HUMAN INTERLEUKIN-2 | FNO32LO217 |
Structural Modifications
Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
---|---|---|---|---|---|---|
INSERTED GENE EXPRESSION VECTOR | UNSPECIFIED SUBSTANCE |
f7697a39
(not in database)
|
||||
VECTOR EXPRESSED PROTEIN | Pomlucabtagene autoleucel CAR-T receptor | C2Z887B3BP |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
ENHANCED ACTIVATION | BIOLOGICAL |
|
|
|||